Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention

医学 动脉粥样硬化性心血管疾病 内科学 心肌梗塞 危险系数 心脏病学 风险评估 置信区间 疾病 计算机安全 计算机科学
作者
In‐Chang Hwang,Chee Hae Kim,Jae Young Kim,Hong‐Mi Choi,Yeonyee E. Yoon,Goo‐Yeong Cho
出处
期刊:Hypertension [Ovid Technologies (Wolters Kluwer)]
卷期号:80 (8): 1697-1706 被引量:4
标识
DOI:10.1161/hypertensionaha.122.20678
摘要

Contemporary cardiovascular primary prevention is based on the assessment of the 10-year risk of atherosclerotic cardiovascular disease (ASCVD). However, the clinical implications of temporal change in the 10-year ASCVD risk estimate (∆10-year ASCVD risk/year) are unknown.A total of 211 077 participants without established ASCVD and with repetitive 10-year ASCVD risk assessment at an interval of 4 to 5 years were selected from the Korean National Health Insurance Service data. The primary end point was a composite of myocardial infarction, stroke, coronary revascularization, and all-cause death.ASCVD event rates were proportional to the ∆10-year ASCVD risk/year regardless of the baseline 10-year ASCVD risk. Adjusted hazard ratio for ASCVD events per 1% increase in ∆10-year ASCVD risk/year was 1.53 (95% CI, 1.44-1.63), 1.24 (95% CI, 1.15-1.32), 1.18 (95% CI, 1.13-1.23), and 1.05 (95% CI, 1.00-1.10) in those with a baseline 10-year ASCVD risk of <5%, 5% to 7.5%, 7.5% to 20%, and ≥20%, respectively. Appropriate control of risk factors, including low-density lipoprotein cholesterol, blood pressure, body mass index, exercise habits, and smoking status, was associated with lower ASCVD event rates, whereas failure to control these risk factors resulted in higher ASCVD event rates.The temporal change in 10-year ASCVD risk over a period of 4 to 5 years reflects success or failure in controlling major cardiovascular risk factors and indicates the risk of future ASCVD events. The ∆10-year ASCVD risk/year can be used as an indicator of primary prevention and guide the application of preventive measures.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
汉堡包应助haster采纳,获得10
1秒前
可爱的函函应助大柯采纳,获得10
1秒前
3秒前
Rollei应助科研通管家采纳,获得10
3秒前
完美世界应助科研通管家采纳,获得10
3秒前
3秒前
Rollei应助科研通管家采纳,获得10
3秒前
Orange应助科研通管家采纳,获得10
3秒前
完美世界应助科研通管家采纳,获得10
3秒前
斯文败类应助科研通管家采纳,获得10
3秒前
Orange应助科研通管家采纳,获得10
3秒前
顾矜应助科研通管家采纳,获得10
3秒前
斯文败类应助科研通管家采纳,获得10
3秒前
Rollei应助科研通管家采纳,获得10
3秒前
顾矜应助科研通管家采纳,获得10
3秒前
Lucas应助科研通管家采纳,获得10
3秒前
Rollei应助科研通管家采纳,获得10
3秒前
幻翎应助科研通管家采纳,获得30
3秒前
Lucas应助科研通管家采纳,获得10
3秒前
危机的阁应助科研通管家采纳,获得50
3秒前
幻翎应助科研通管家采纳,获得30
3秒前
子车茗应助科研通管家采纳,获得20
3秒前
危机的阁应助科研通管家采纳,获得50
3秒前
CipherSage应助科研通管家采纳,获得10
3秒前
子车茗应助科研通管家采纳,获得20
3秒前
英俊的铭应助科研通管家采纳,获得10
3秒前
CipherSage应助科研通管家采纳,获得10
4秒前
科目三应助科研通管家采纳,获得10
4秒前
英俊的铭应助科研通管家采纳,获得10
4秒前
慕青应助科研通管家采纳,获得10
4秒前
科目三应助科研通管家采纳,获得10
4秒前
子车茗应助科研通管家采纳,获得20
4秒前
深情安青应助科研通管家采纳,获得10
4秒前
慕青应助科研通管家采纳,获得10
4秒前
BowieHuang应助科研通管家采纳,获得10
4秒前
子车茗应助科研通管家采纳,获得20
4秒前
ding应助科研通管家采纳,获得10
4秒前
eblog发布了新的文献求助10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
从k到英国情人 1500
Ägyptische Geschichte der 21.–30. Dynastie 1100
„Semitische Wissenschaften“? 1100
Real World Research, 5th Edition 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5735163
求助须知:如何正确求助?哪些是违规求助? 5358806
关于积分的说明 15328740
捐赠科研通 4879501
什么是DOI,文献DOI怎么找? 2621999
邀请新用户注册赠送积分活动 1571173
关于科研通互助平台的介绍 1527966